 Matthew Stone
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 10 | 2022 | 609 | 2.920 |
Why?
| | Heart Septal Defects, Ventricular | 3 | 2022 | 46 | 1.830 |
Why?
| | Ventricular Outflow Obstruction | 2 | 2022 | 40 | 1.460 |
Why?
| | Computed Tomography Angiography | 2 | 2023 | 145 | 1.420 |
Why?
| | Aortic Diseases | 3 | 2022 | 124 | 1.380 |
Why?
| | Double Outlet Right Ventricle | 2 | 2022 | 9 | 1.340 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2022 | 392 | 1.300 |
Why?
| | Aortic Valve Stenosis | 4 | 2023 | 253 | 1.190 |
Why?
| | Heart Transplantation | 4 | 2023 | 736 | 1.020 |
Why?
| | Fontan Procedure | 4 | 2023 | 191 | 1.010 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2021 | 120 | 0.930 |
Why?
| | Ventricular Function, Left | 6 | 2023 | 541 | 0.870 |
Why?
| | Central Venous Catheters | 2 | 2022 | 52 | 0.780 |
Why?
| | Postoperative Complications | 7 | 2020 | 2919 | 0.770 |
Why?
| | Aortic Coarctation | 1 | 2023 | 79 | 0.760 |
Why?
| | Coronary Circulation | 2 | 2022 | 136 | 0.760 |
Why?
| | Heart Defects, Congenital | 4 | 2023 | 914 | 0.750 |
Why?
| | Pulmonary Atresia | 1 | 2022 | 22 | 0.740 |
Why?
| | Fibroma | 1 | 2022 | 20 | 0.740 |
Why?
| | Atrioventricular Block | 1 | 2022 | 45 | 0.720 |
Why?
| | Heart Neoplasms | 1 | 2022 | 55 | 0.720 |
Why?
| | Catheterization, Central Venous | 2 | 2022 | 122 | 0.710 |
Why?
| | Aorta, Thoracic | 2 | 2023 | 286 | 0.700 |
Why?
| | Hemodynamics | 3 | 2021 | 1121 | 0.690 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 5 | 0.670 |
Why?
| | Coronary Vessels | 1 | 2022 | 251 | 0.650 |
Why?
| | Echocardiography | 1 | 2023 | 652 | 0.650 |
Why?
| | Coronary Angiography | 1 | 2022 | 323 | 0.650 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 316 | 0.600 |
Why?
| | Child | 19 | 2023 | 22633 | 0.580 |
Why?
| | Vascular Stiffness | 2 | 2020 | 486 | 0.570 |
Why?
| | Primary Graft Dysfunction | 1 | 2019 | 35 | 0.570 |
Why?
| | Tissue and Organ Procurement | 1 | 2022 | 346 | 0.560 |
Why?
| | Anesthesia, Cardiac Procedures | 1 | 2018 | 27 | 0.550 |
Why?
| | Vena Cava, Inferior | 1 | 2018 | 81 | 0.540 |
Why?
| | Septal Occluder Device | 1 | 2018 | 36 | 0.540 |
Why?
| | Nicardipine | 1 | 2017 | 6 | 0.540 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 2115 | 0.540 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 197 | 0.530 |
Why?
| | Infant | 9 | 2023 | 10034 | 0.510 |
Why?
| | Heart Ventricles | 5 | 2023 | 760 | 0.510 |
Why?
| | Laparoscopy | 2 | 2012 | 475 | 0.500 |
Why?
| | Calcium Channel Blockers | 1 | 2017 | 165 | 0.490 |
Why?
| | Cardiac Catheterization | 3 | 2022 | 560 | 0.490 |
Why?
| | Aortic Valve | 3 | 2023 | 365 | 0.430 |
Why?
| | Respiration, Artificial | 1 | 2019 | 708 | 0.430 |
Why?
| | Humans | 43 | 2023 | 144759 | 0.400 |
Why?
| | Surgical Procedures, Operative | 2 | 2013 | 270 | 0.390 |
Why?
| | Catheters, Indwelling | 1 | 2013 | 96 | 0.380 |
Why?
| | Aortic Stenosis, Supravalvular | 1 | 2012 | 4 | 0.360 |
Why?
| | Ethics, Medical | 1 | 2012 | 87 | 0.360 |
Why?
| | Coronary Sinus | 1 | 2012 | 9 | 0.360 |
Why?
| | Retrospective Studies | 11 | 2023 | 17066 | 0.360 |
Why?
| | Peritoneal Dialysis | 1 | 2013 | 100 | 0.350 |
Why?
| | Esophageal Achalasia | 1 | 2012 | 29 | 0.350 |
Why?
| | Pericardium | 1 | 2012 | 62 | 0.350 |
Why?
| | Health Resources | 1 | 2013 | 129 | 0.350 |
Why?
| | Hernia, Diaphragmatic | 1 | 2011 | 67 | 0.340 |
Why?
| | Renal Insufficiency | 1 | 2013 | 168 | 0.340 |
Why?
| | Infant, Newborn | 6 | 2023 | 6429 | 0.330 |
Why?
| | Tobacco Products | 2 | 2022 | 84 | 0.330 |
Why?
| | Treatment Outcome | 11 | 2022 | 11679 | 0.330 |
Why?
| | Suture Techniques | 1 | 2011 | 131 | 0.320 |
Why?
| | Diagnostic Errors | 1 | 2012 | 175 | 0.320 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2012 | 197 | 0.310 |
Why?
| | Insurance, Health | 1 | 2013 | 302 | 0.310 |
Why?
| | Child, Preschool | 8 | 2022 | 11787 | 0.290 |
Why?
| | Tetralogy of Fallot | 2 | 2020 | 76 | 0.290 |
Why?
| | Hospital Mortality | 2 | 2013 | 1030 | 0.290 |
Why?
| | Male | 24 | 2023 | 72315 | 0.280 |
Why?
| | Hypertension | 1 | 2017 | 1263 | 0.280 |
Why?
| | Smoking Cessation | 2 | 2022 | 439 | 0.270 |
Why?
| | Esophageal Neoplasms | 1 | 2012 | 347 | 0.260 |
Why?
| | Incidence | 5 | 2022 | 2879 | 0.260 |
Why?
| | Aorta | 4 | 2020 | 429 | 0.260 |
Why?
| | Female | 23 | 2023 | 78271 | 0.250 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2023 | 214 | 0.230 |
Why?
| | Heart | 2 | 2020 | 636 | 0.230 |
Why?
| | Product Labeling | 2 | 2022 | 11 | 0.220 |
Why?
| | Pulmonary Artery | 3 | 2020 | 1134 | 0.220 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 2 | 2023 | 45 | 0.220 |
Why?
| | Adenocarcinoma | 1 | 2012 | 928 | 0.210 |
Why?
| | Time Factors | 6 | 2022 | 7173 | 0.210 |
Why?
| | Jugular Veins | 2 | 2022 | 42 | 0.200 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 41 | 0.190 |
Why?
| | Sternotomy | 1 | 2022 | 23 | 0.190 |
Why?
| | Calcinosis | 2 | 2023 | 234 | 0.190 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 113 | 0.180 |
Why?
| | Fetal Diseases | 1 | 2023 | 191 | 0.170 |
Why?
| | Trachea | 2 | 2021 | 261 | 0.170 |
Why?
| | Risk Factors | 6 | 2022 | 10779 | 0.160 |
Why?
| | Norwood Procedures | 1 | 2021 | 29 | 0.160 |
Why?
| | Waiting Lists | 1 | 2022 | 263 | 0.160 |
Why?
| | Cardiopulmonary Bypass | 1 | 2022 | 221 | 0.160 |
Why?
| | Cigarette Smoking | 1 | 2021 | 99 | 0.160 |
Why?
| | Killer Cells, Natural | 1 | 2023 | 467 | 0.150 |
Why?
| | Adolescent | 6 | 2021 | 22428 | 0.150 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2021 | 108 | 0.150 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 195 | 0.140 |
Why?
| | Cannula | 1 | 2018 | 27 | 0.140 |
Why?
| | Young Adult | 4 | 2020 | 14105 | 0.140 |
Why?
| | Recurrence | 1 | 2021 | 1135 | 0.140 |
Why?
| | Smoking | 2 | 2022 | 1472 | 0.130 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 842 | 0.130 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 917 | 0.130 |
Why?
| | Heart-Assist Devices | 2 | 2012 | 567 | 0.120 |
Why?
| | Case-Control Studies | 2 | 2021 | 3604 | 0.110 |
Why?
| | Reproducibility of Results | 1 | 2022 | 3409 | 0.110 |
Why?
| | Research Design | 1 | 2020 | 1135 | 0.100 |
Why?
| | Double-Blind Method | 1 | 2018 | 2029 | 0.100 |
Why?
| | Pandemics | 1 | 2022 | 1694 | 0.100 |
Why?
| | Risk Assessment | 3 | 2019 | 3671 | 0.100 |
Why?
| | Rural Health | 1 | 2013 | 87 | 0.100 |
Why?
| | Bronchiolitis Obliterans | 1 | 2013 | 66 | 0.090 |
Why?
| | Hospital Charges | 1 | 2013 | 46 | 0.090 |
Why?
| | Catheterization | 1 | 2013 | 183 | 0.090 |
Why?
| | Risk Adjustment | 1 | 2013 | 85 | 0.090 |
Why?
| | Tricuspid Valve | 1 | 2012 | 41 | 0.090 |
Why?
| | Medically Uninsured | 1 | 2013 | 129 | 0.090 |
Why?
| | Ventricular Fibrillation | 1 | 2012 | 64 | 0.090 |
Why?
| | Cryosurgery | 1 | 2012 | 47 | 0.090 |
Why?
| | Mitral Valve | 1 | 2012 | 96 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 2608 | 0.090 |
Why?
| | Sirolimus | 1 | 2013 | 281 | 0.090 |
Why?
| | Anxiety | 1 | 2019 | 1109 | 0.090 |
Why?
| | Perfusion | 1 | 2012 | 250 | 0.080 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2012 | 222 | 0.080 |
Why?
| | Fatal Outcome | 1 | 2012 | 307 | 0.080 |
Why?
| | Esophagectomy | 1 | 2012 | 135 | 0.080 |
Why?
| | Linear Models | 1 | 2013 | 854 | 0.080 |
Why?
| | Logistic Models | 2 | 2013 | 2117 | 0.080 |
Why?
| | Tachycardia, Ventricular | 1 | 2012 | 181 | 0.080 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 323 | 0.080 |
Why?
| | Medicare | 2 | 2013 | 886 | 0.080 |
Why?
| | Age Factors | 1 | 2017 | 3333 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2013 | 449 | 0.080 |
Why?
| | Systole | 2 | 2020 | 178 | 0.080 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2012 | 237 | 0.080 |
Why?
| | Radiography | 1 | 2012 | 844 | 0.070 |
Why?
| | Cattle | 1 | 2012 | 1000 | 0.070 |
Why?
| | Health Care Costs | 1 | 2012 | 427 | 0.070 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1539 | 0.070 |
Why?
| | Heart Valve Diseases | 1 | 2010 | 151 | 0.070 |
Why?
| | Lung Transplantation | 1 | 2012 | 338 | 0.070 |
Why?
| | Prospective Studies | 2 | 2018 | 7990 | 0.070 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2011 | 219 | 0.070 |
Why?
| | Medicaid | 1 | 2013 | 461 | 0.070 |
Why?
| | Intensive Care Units | 1 | 2014 | 916 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1489 | 0.070 |
Why?
| | Cohort Studies | 3 | 2023 | 5960 | 0.060 |
Why?
| | Stroke Volume | 2 | 2020 | 651 | 0.060 |
Why?
| | Databases, Factual | 1 | 2013 | 1486 | 0.060 |
Why?
| | Length of Stay | 1 | 2013 | 1337 | 0.060 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 529 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2014 | 5408 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2023 | 4154 | 0.050 |
Why?
| | Prognosis | 1 | 2012 | 4282 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2023 | 160 | 0.050 |
Why?
| | Virginia | 2 | 2014 | 55 | 0.050 |
Why?
| | United States | 3 | 2021 | 15966 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2023 | 110 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2010 | 865 | 0.050 |
Why?
| | Thymus Gland | 1 | 2023 | 311 | 0.050 |
Why?
| | Adenosine Triphosphatases | 1 | 2023 | 162 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 331 | 0.040 |
Why?
| | Smokers | 1 | 2022 | 137 | 0.040 |
Why?
| | Aged | 6 | 2021 | 25913 | 0.040 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 12 | 0.040 |
Why?
| | Middle Aged | 7 | 2021 | 35875 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 673 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 1 | 2011 | 2730 | 0.040 |
Why?
| | Tobacco Use | 1 | 2021 | 61 | 0.040 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 37 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 45 | 0.040 |
Why?
| | Adult | 5 | 2021 | 40449 | 0.040 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2020 | 49 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 197 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 198 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 150 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2323 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3863 | 0.040 |
Why?
| | Lung | 1 | 2012 | 4109 | 0.040 |
Why?
| | Regional Blood Flow | 1 | 2021 | 514 | 0.040 |
Why?
| | Myocardial Contraction | 1 | 2020 | 298 | 0.040 |
Why?
| | Blotting, Western | 1 | 2021 | 1187 | 0.030 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 413 | 0.030 |
Why?
| | Signal Transduction | 2 | 2023 | 5226 | 0.030 |
Why?
| | Myocardium | 1 | 2023 | 939 | 0.030 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 276 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1886 | 0.030 |
Why?
| | Ventricular Function, Right | 1 | 2020 | 297 | 0.030 |
Why?
| | Animals | 3 | 2013 | 38058 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 935 | 0.030 |
Why?
| | RNA | 1 | 2021 | 940 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2947 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 89 | 0.020 |
Why?
| | Receptors, CXCR4 | 1 | 2013 | 91 | 0.020 |
Why?
| | Citrates | 1 | 2012 | 41 | 0.020 |
Why?
| | Warm Ischemia | 1 | 2012 | 18 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 64 | 0.020 |
Why?
| | Organ Preservation Solutions | 1 | 2012 | 47 | 0.020 |
Why?
| | Cost Savings | 1 | 2012 | 86 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 119 | 0.020 |
Why?
| | Cold Ischemia | 1 | 2012 | 40 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2013 | 4557 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 415 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 4271 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 136 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 271 | 0.020 |
Why?
| | Reoperation | 1 | 2014 | 630 | 0.020 |
Why?
| | Cold Temperature | 1 | 2012 | 209 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 254 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2012 | 547 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2012 | 395 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1253 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2012 | 357 | 0.020 |
Why?
| | Vasoconstrictor Agents | 1 | 2010 | 144 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 634 | 0.020 |
Why?
| | Risk | 1 | 2012 | 911 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 2012 | 300 | 0.020 |
Why?
| | Survival Rate | 1 | 2014 | 2089 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 509 | 0.020 |
Why?
| | Survival Analysis | 1 | 2012 | 1382 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1306 | 0.020 |
Why?
| | Tissue Donors | 1 | 2012 | 424 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7190 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 201 | 0.020 |
Why?
| | Cell Movement | 1 | 2013 | 965 | 0.020 |
Why?
| | Heart Arrest | 1 | 2012 | 407 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 379 | 0.020 |
Why?
| | Odds Ratio | 1 | 2010 | 1075 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2012 | 1095 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1217 | 0.020 |
Why?
| | Contrast Media | 1 | 2010 | 488 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6048 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1325 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5992 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8265 | 0.010 |
Why?
| | Mice | 1 | 2013 | 18339 | 0.010 |
Why?
|
|
Stone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|